Aciclovir topical formulation - Yissum

Drug Profile

Aciclovir topical formulation - Yissum

Alternative Names: Acyclovir-topical formulation; P-0964a

Latest Information Update: 17 Apr 2007

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Yissum Research Development Company
  • Class
  • Mechanism of Action DNA-directed DNA polymerase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Herpes simplex virus infections

Most Recent Events

  • 17 Apr 2006 Discontinued - Clinical-Phase-Unknown for Herpes simplex virus infections in Israel (Topical)
  • 05 Oct 2001 Investigation in Herpes simplex virus infections in Israel (Topical)
  • 03 Oct 2001 New profile
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top